All nine Fine Fettle cannabis dispensaries across Connecticut will serve both medical patients and adult-use customers starting Thursday, following a new state law. Company leaders describe the shift as a conversion of their recreational retail sites into hybrid facilities eligible to participate in the Connecticut Medical Marijuana program. This change aims to boost access for patients who previously faced travel burdens or limited options.
Legislative Shift Opens Doors for Hybrids
Connecticut legalized recreational cannabis sales in 2021, building on its medical marijuana program established nearly a decade earlier. Recent regulations now permit existing recreational retailers to apply for hybrid status, allowing them to cater to registered medical patients alongside adult-use buyers. Fine Fettle completed conversions at every location to align with these rules, a move praised by its COO, Benjamin Zachs, for sustaining the state's medical framework.
Addressing Access and Equity Gaps
Zachs emphasized efficiency and equity in a statement, noting that patients often lack nearby options in certain regions. The hybrid model lets Fine Fettle maintain its focus on quality care and expertise while expanding service reach. Patients gain convenience without long drives, and the company positions itself to support both groups responsibly under state oversight from the Department of Consumer Protection.
Company Presence Spans Multiple States
Fine Fettle operates in Manchester, Norwalk, Old Saybrook, Waterbury, West Hartford, and additional Connecticut sites. Beyond the state, it runs retail locations in Massachusetts and Georgia, where cannabis markets vary in maturity and rules. This nationwide footprint underscores Fine Fettle's adaptation to evolving regulations, potentially setting a template for other operators to enhance medical program participation.
